Inhibition of rat α-reductases by finasteride: Evidence for isozyme differences in the mechanism ofinhibition

Journal of Steroid Biochemistry and Molecular Biology

Volumn 61, Issue 1-2, 1997, Pages 55-64

  Azzolina, B ^a   Ellsworth, K ^a   Andersson, S ^b   Geissler, W ^a   Bull, H G ^a   Harris, G S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; ISOENZYME; RECOMBINANT ENZYME; STEROID 5ALPHA REDUCTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME ISOLATION; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; RAT;

ANIMALS; COS CELLS; ENZYME INHIBITORS; FINASTERIDE; HEAT; ISOENZYMES; KINETICS; NADP; PROTEIN DENATURATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; TESTOSTERONE 5-ALPHA-REDUCTASE;

ANIMALIA;

EID: 0030850566     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00002-2     Document Type: Article

References (39)

1. Wilson J. D., Griffin J. E. and Russell D. W.: Steroid 5α-reductase 2 deficiency. Endocr. Rev. 14 (1993) 577-593.
2. Imperato-McGinley J., Guerrero L., Gautier T. and Peterson R. E.: Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 21 (1974) 1213-1215.
3. Peterson R. E., Imperato-McGinley J., Gautier T. and Sturla E.: Male pseudohermaphroditism due to steroid 5α-reductase deficiency. Am. J. Med. 62 (1977) 170-191.
4. Imperato-McGinley J. and Gautier T.: Inherited 5α-reductase deficiency in man. Trends Genet. 2 (1986) 130-133.
5. Imperato-McGinley J., Gautier T., Cai L. Q., Yee B., Epstein J. and Pochi P.: The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J. Clin. Endocr. Metab. 76 (1993) 524-528.
6. Liang T., Cascieri M., Cheung A., Reynolds G. and Rasmusson G.: Species differences in prostatic steroid 5α-reductases of rat, human and dog. Endocrinology 117 (1985) 571-579.
7. Gormley G. J., Stoner E., Bruskewitz R. C., Imperato-McGinley J., Walsh P. C., McConnell J. D., Andriole G. L., Geller J., Bracken B., Tenover J. S., Baughan E. D., Pappas F., Taylor A., Binkowitz B., Ng J. and Group F. S.: The effect of finasteride in men with benign prostatic hyperplasia. N. EngL. J. Med. 327 (1992) 1185-1191.
8. Levy M. A., Brandt M., Heys R., Holt D. A. and Metcalf B. W.: Inhibition of rat liver steroid 5α-reductase by 3-androstene-3-carboxylic acids: mechanism of enzyme inhibitor interaction. Biochemistry 29 (1990) 2815-2824.
9. Audet P., Nurcombe H., Lamb Y., Jorasky D., Lloyd-Davis K. and Morris: Effect of multiple doses of epristeride (E) a steroid 5α-reductase inhibitor on serum dihydrotestosterone in older male subjects. Clin. Pharmacol Ther. 53 (1993) 231.
10. Hirosumi J., Nakayama O., Fagan R., Sawada K., Chida N., Inami M., Takahashi S., Kojo H., Notsu Y. and Okuhara M.: FK143, a novel nonsteroidal inhibitor of steroid 5α-reductase: (I) In vitro effects on human and animal prostatic enzymes. J. Steroid Biochem. Molec. Biol. 52 (1995) 357-363.
11. di Salle E., Guidici D., Briatico G., Ornati G. and Panzeri A.: Hormonal effects of turosteride, a 5-alpha-reductase inhibitor, in the rat. J. Steroid Biochem. Molec. Biol. 46 (1993) 549-555.
12. Frye S. V., Haffner C. D., Maloney P. R., Mook R. A. Jr, Dorsey G. F., Hiner R. N., Batchelor K. W., Bramson H. N., Stuart J. D., Schweiker S. L., van Arnold J., Bickett D. M., Moss M. L., Tian G., Unwalla R. J., Lee F. W., Tippin T. K., James M. K., Grizzle M. K., Long J. E. and Schuster S. V.: 6-azasteroids: Potent dual inhibitors of human type 1 and 2 steroid 5α-reductase. J. Med. Chem. 36 (1993) 4313-4315.
13. 5-isomerase. J. Med. Chem. 37 (1994) 2352-2360.
14. Brooks J. R., Berman C., Primka R. L., Reynolds G. F. and Rasmusson G. H.: Five-alpha-reductase inhibitory and antiandrogenic activities of some 4-azasteroids in the rat. Steroids 47 (1986) 1-19.
15. Clark R. L., Antonello J. M., Grossman S. J., Wise L. D., Anderson C., Bagdon W. J., Prahalada S., MacDonald J. S. Robertson R. T.: External genitalia abnormalities in male rats exposed in utero to finasteride, a 5α-reductase inhibitor. Teratology 42 (1990) 91-100.
16. Clark R. L., Anderson C. A., Prahalada S., Robertson R. T., Lochry E. A., Leonard Y. M., Stevens J. L. and Hoverman A. M.: Critical developmental periods for effects on male rat genitalia induced by finasteride, a 5α-reductase inhibitor. Toxicol. Appl. Pharmacol. 119 (1993) 34-40.
17. Imperato-McGinley J., Binienda Z., Arthur A., Mininberg D. T., Vaugh J. E.D. and Quimby F. W.: The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5α-reductase. Endocrinology 116 (1985) 807-812.
18. Andersson S., Bishop R. W. and Russell D. W.: Expression cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J. Biol. Chem. 12 (1989) 16249-16255.
19. Andersson S., Berman D. M., Jenkins E. P. and Russell D. W.: Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 354 (1991) 159-161.
20. Normington K. and Russell D. W.: Tissue distribution of kinetic characteristics of rat steroid 5α-reductase isozymes. J. Biol. Chem. 267 (1992) 19548-19554.
21. Levy M. A., Brandt M., Sheedy K. M., Holt D. A., Heaslip J. I., Trill J. J., Ryan P. J., Morris R. A., Garrison L. M. and Bergsma D. J.: Cloning, expression and functional characterization of type 1 and type 2 steroid 5-alpha-reductases from cynomolgus monkey: comparisons with human and rat isozymes. J. Steroid Biochem. Molec. Biol. 54 (1995) 307-319.
22. Thigpen A. E., Silver R. I., Guileyardo J. M., Casey M. L., McConnell J. D. and Russell D. W.: Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J. Clin. Invest. 92 (1993) 903-910.
23. Levy M., Metcalf B. W., Brandt M., Erb J. M., Oh H.-J., Geaslip J. I., Yen H.-K., Rozamus L. W. and Holt D. A.: 3-Phosphinic acid and 3-phosphonic acid steroids as inhibitors of steroid 5α-reductase: species comparison and mechanistic studies. Bioorg. Chem. 19 (1991) 245-260.
24. Holt C. A., Levy M. A., Yen H.-W., Oh H.-J. and Metcalf B. W.: Inhibition of steroid 5α-reductase by 3-nitrosteroids: synthesis, mechanism, of inhibition, and in vivo activity. Bioorg. Med. Chem. Lett. 1 (1991) 27-32.
25. Rhodes L., Harper J., Uno H., Gaito G., Audettearruda J., Kurata S., Berman C., Primka R. and Pikounis B.: The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptial macaques (Macaca, arcotoides). J. Clin. Endocr. Metab. 79 (1994) 991-996.
26. Rittmaster R. S., Uno J., Povar M. L., Mellin T. N. and Loriaux D. L.: The effects of n,n-diethyl-4-methyl-3-oxo-4-aza-5-alpha-androstane-17-beta-carboxamide a 5-alpha reductase inhibitor and antiandrogen on the development of baldness in the stumptail macaque. J. Clin. Endocr. Metab. 65 (1987) 188-193.
27. Faller B., Farley D. and Nick H.: Finasteride: a slow-binding 5α-reductase inhibitor. Biochemistry. 32 (1993) 5705-5710.
28. Tian G., Stuart J. D., Moss M. L., Domanico P. L., Bramson H. N., Patel I. R., Kadwell S. H., Overton L. K., Kost T. A., Mook R. A. Jr, Frye S. V., Batchelor K. W. and Wiseman J. S.: 17β-(N-tert-butylcarbamoyl)-4-aza-5α-androstan-1-en-3-one is an active site directed slow time-dependent inhibitor of human steroid 5α-reductase 1. Biochemistry 33 (1994) 2291-2296.
29. Bull H. G., Garcia-Calvo M., Andersson S. A., Baginsky W. F., Chan H. K., Ellsworth D., Miller R., Stearns R. A., Bakshi R. K., Rasmusson G. H., Tolman R. L., Myers R. W., Kozarich J. W. and Harris G. S.: Mechanism-based inhibition of human steroid 5α-reductase by finasteride: enzyme catalyzed formation of NADP-dihydrofinasteride, a potent bisubstrate analog inhibitor. J. Am. Chem. Soc. 118 (1996) 2359-2365.
30. Liang T., Heiss C. E., Ostrove S., Rasmusson G. H. and Cheung A.: Binding of a 4-methyl-4-azasteroid to 5α-reductase of rat liver and prostate microsomes. Endocrinology 112 (1983) 1460-1468.
31. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275.
32. Andersson A., Davis D. L., Dahlbäck H., Jörnvall H. and Russell D. W.: Cloning, structure and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol Chem. 264 (1989) 8222-8229.
33. Harris G., Azzolina B., Baginsky W., Cimis G., Rasmusson G. H., Tolman R. L., Raetz C. R. H. and Ellsworth K.: Identification and selective inhibition of an isozyme of steroid 5α-reductase in human scalp. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10787-10791.
34. Morrison J. F. and Walsh C. T.: The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Molec. Biol. 61 (1988) 201-301.
35. Thigpen A. E., Cala K. M. and Russell D. W.: Characterization of Chinese hamster ovary cell lines expressing human steroid 5α-reductase isozymes. J. Biol. Chem. 268 (1993) 17404-17412.
36. Levy M. A., Brandt J. and Greway A. T.: Mechanistic studies with solubilized rat liver steroid 5α-reductase: elucidation of the kinetic mechanism. Biochemistry 29 (1990) 2808-2815.
37. Ichihara K. and Tanaka C.: Some properties of progesterone 5α-reductase solubilized from rat liver microsomes. Biochem. Int. 15 (1987) 1005-1011.
38. Wigley W. C., Prihoda J. S., Mowszowicz I., Mendonca B. B., New M. I., Wilson J. D. and Russell D. W.: Natural mutagenesis study of the human steroid 5α-reductase 2 isozyme. Biochemistry 33 (1994) 1265-1270.
39. Andersson S. and Russell D. W.: Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3640-3644.